Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis.

Ha IS, Yap HK, Munarriz RL, Zambrano PH, Flynn JT, Bilge I, Szczepanska M, Lai WM, Antonio ZL, Gulati A, Hooman N, van Hoeck K, Higuita LM, Verrina E, Klaus G, Fischbach M, Riyami MA, Sahpazova E, Sander A, Warady BA, Schaefer F; International Pediatric Peritoneal Dialysis Network Registry..

Kidney Int. 2015 Sep;88(3):605-13. doi: 10.1038/ki.2015.108.

2.

Complications after primary bladder exstrophy closure - role of pelvic osteotomy.

Baka-Ostrowska M, Kowalczyk K, Felberg K, Wawer Z.

Cent European J Urol. 2013;66(1):104-8. doi: 10.5173/ceju.2013.01.art31.

3.

[Vitamin D status in children with renal diseases].

Pańczyk-Tomaszewska M, Mizerska-Wasiak M, Ziółkowska H, Adamczuk D, Kisiel A, Wawer Z, Kamińska A, Roszkowska-Blaim M.

Med Wieku Rozwoj. 2013 Oct-Dec;17(4):306-12. Polish.

4.

[Significance of early diagnosis of posterior urethral valves in fetus for further development - own experience].

Krzemień G, Szmigielska A, Wawer Z, Roszkowska-Blaim M.

Med Wieku Rozwoj. 2013 Oct-Dec;17(4):301-5. Polish.

5.

Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.

Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.

Clin Nephrol. 2014 Mar;81(3):166-73. doi: 10.5414/CN108044.

PMID:
24361057
6.

Management of anemia in children receiving chronic peritoneal dialysis.

Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, Munarriz RL, Chua A, Pesle S, Emre S, Urzykowska A, Quiroz L, Ruscasso JD, White C, Pape L, Ramela V, Printza N, Vogel A, Kuzmanovska D, Simkova E, Müller-Wiefel DE, Sander A, Warady BA, Schaefer F; International Pediatric Peritoneal Dialysis Network (IPPN) Registry..

J Am Soc Nephrol. 2013 Mar;24(4):665-76. doi: 10.1681/ASN.2012050433.

7.

Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy.

Sladowska-Kozłowska J, Litwin M, Niemirska A, Płudowski P, Wierzbicka A, Skorupa E, Wawer ZT, Janas R.

Pediatr Nephrol. 2012 Oct;27(10):1943-51. doi: 10.1007/s00467-012-2193-x.

8.

Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension.

Sladowska-Kozłowska J, Litwin M, Niemirska A, Wierzbicka A, Wawer ZT, Janas R.

Pediatr Nephrol. 2011 Dec;26(12):2201-9. doi: 10.1007/s00467-011-1916-8.

9.

Regression of target organ damage in children and adolescents with primary hypertension.

Litwin M, Niemirska A, Sladowska-Kozlowska J, Wierzbicka A, Janas R, Wawer ZT, Wisniewski A, Feber J.

Pediatr Nephrol. 2010 Dec;25(12):2489-99. doi: 10.1007/s00467-010-1626-7.

10.

Inflammatory activation in children with primary hypertension.

Litwin M, Michałkiewicz J, Niemirska A, Gackowska L, Kubiszewska I, Wierzbicka A, Wawer ZT, Janas R.

Pediatr Nephrol. 2010 Sep;25(9):1711-8. doi: 10.1007/s00467-010-1548-4. Erratum in: Pediatr Nephrol. 2010 Dec;25(12):2549. Gockowska, Lidia [corrected to Gackowska, Lidia].

PMID:
20495830
11.

Evolution of large-vessel arteriopathy in paediatric patients with chronic kidney disease.

Litwin M, Wühl E, Jourdan C, Niemirska A, Schenk JP, Jobs K, Grenda R, Wawer ZT, Rajszys P, Mehls O, Schaefer F.

Nephrol Dial Transplant. 2008 Aug;23(8):2552-7. doi: 10.1093/ndt/gfn083.

12.

Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension.

Litwin M, Sladowska J, Syczewska M, Niemirska A, Daszkowska J, Antoniewicz J, Wierzbicka A, Wawer ZT.

Pediatr Nephrol. 2008 May;23(5):787-96. doi: 10.1007/s00467-007-0739-0.

PMID:
18253758
13.

Metabolic abnormalities, insulin resistance, and metabolic syndrome in children with primary hypertension.

Litwin M, Sladowska J, Antoniewicz J, Niemirska A, Wierzbicka A, Daszkowska J, Wawer ZT, Janas R, Grenda R.

Am J Hypertens. 2007 Aug;20(8):875-82.

PMID:
17679036
14.

[Oxidative stress and hypertensive arteriopathy in children with primary hypertension--preliminary results].

Sladowska J, Wierzbicka A, Litwin M, Antoniewicz J, Niemirska A, Wawer Z, Socha P, Skorupa E, Grenda R.

Przegl Lek. 2006;63 Suppl 3:107-10. Polish.

PMID:
16898503
15.

[Target organ damage in children with newly diagnosed and untreated essential hypertension].

Antoniewicz J, Litwin M, Daszkoska J, Niemirska A, Sladowska J, Wierzbicka A, Wawer Z, Grenda R.

Przegl Lek. 2006;63 Suppl 3:101-6. Polish.

PMID:
16898502
16.

[Fat tissue distribution and metabolic alterations in boys with primary hypertension].

Niemirska A, Litwin M, Antoniewicz J, Jurkiewicz E, Kościesza I, Sladowska J, Janas R, Wawer ZT.

Przegl Lek. 2006;63 Suppl 3:49-53. Polish.

PMID:
16898487
17.

[Efficacy and safety of cyclosporine in the treatment of inflammatory bowel disease in children - a retrospective study].

Socha P, Wawer Z, Ryzko J, Orłowska E, Szczepański M, Kierkus J, Celińska-Cedro D, Socha J.

Med Wieku Rozwoj. 2006 Apr-Jun;10(2):429-35. Polish.

PMID:
16825713
18.

Left ventricular hypertrophy and arterial wall thickening in children with essential hypertension.

Litwin M, Niemirska A, Sladowska J, Antoniewicz J, Daszkowska J, Wierzbicka A, Wawer ZT, Grenda R.

Pediatr Nephrol. 2006 Jun;21(6):811-9.

PMID:
16565870
19.

Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation.

Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Tröger J, Mehls O, Schaefer F.

J Am Soc Nephrol. 2005 May;16(5):1494-500.

20.

Intima-media thickness and arterial elasticity in hypertensive children: controlled study.

Litwin M, Trelewicz J, Wawer Z, Antoniewicz J, Wierzbicka A, Rajszys P, Grenda R.

Pediatr Nephrol. 2004 Jul;19(7):767-74.

PMID:
15138871
Items per page

Supplemental Content

Loading ...
Support Center